Product Information
EFAVIRENZ 600 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $1.4318 per EA under NDC 65862004930. Its NADAC has been published 267 times since Oct 14, 2020.
Strength
600 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862004930
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EFAVIRENZApproval Type
Generic (ANDA)
FDA Application
ANDA077673On Market Since
9/21/2018
Pharmacological Classes
Price Statistics
The NADAC for EFAVIRENZ 600 MG TABLET has been published 267 times since Oct 14, 2020, and over the history we have for it it has declined 84.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4318 per EA |
|---|---|
| All-time high | $9.0741 (Dec 16, 2020) |
| All-time low | $1.3206 (Feb 19, 2025) |
| 52-week high | $1.7446 |
| 52-week low | $1.3661 |
| Median price | $2.7606 |
| Average price | $3.5445 |
| Largest weekly change | -43.3% (Mar 22, 2023) |
| Weeks tracked | 267 |
| Tracking since | Oct 14, 2020 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EFAVIRENZ 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EFAVIRENZ 600 MG TABLET, manufactured by Aurobindo Pharma Limited, is $1.4318 per EA (NDC 65862004930), effective Jun 24, 2026.
How has the price of EFAVIRENZ 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for EFAVIRENZ 600 MG TABLET has declined 84.2%. It has been tracked across 267 weekly CMS publications since Oct 14, 2020.
What are the highest and lowest recorded NADAC prices for EFAVIRENZ 600 MG TABLET?
Since Oct 14, 2020, the NADAC for EFAVIRENZ 600 MG TABLET has ranged from a low of $1.3206 (Feb 19, 2025) to a high of $9.0741 (Dec 16, 2020), with a median of $2.7606 per EA.
Are there cheaper alternatives to EFAVIRENZ 600 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as EFAVIRENZ 600 MG TABLET, but none are currently priced below it.
Who manufactures EFAVIRENZ 600 MG TABLET?
EFAVIRENZ 600 MG TABLET (NDC 65862004930) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification